Tradestie Institutional Equity Comparison Engine
BHST vs GLPG โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
GLPG Overall Edge
GLPG Captures Institutional Edge (4โ0 Pillars ยท 9โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Galapagos NV (GLPG) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BHST trades at N/M Forward P/E with -18.0% operating margin (+3.8% YoY revenue) versus GLPG at N/M Forward P/E and 88.0% operating margin (+1093.2% YoY). In options structure, BHST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GLPG sits in UNCLASSIFIED (2nd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
GLPG
BHST N/M vs GLPG N/M Fwd P/E
Growth & Margin Winner
GLPG
Op Margin -18.0% vs 88.0% ยท YoY +3.8% vs +1093.2%
Momentum & Technical Winner
GLPG
1Y -79.4% vs +5.6% ยท 52W Pos 6% vs 23%
Options & Structure Winner
GLPG
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (2nd %ile IV)
BHST
NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap
$29.9M
1M Return
-22.62%
1Y Return
-79.4%
Forward P/E
N/M
Unified AI Score
58.2 / 100
HOLD
Tech 75.0
Fund 57.0
Flow 50.0
Mom 60.0
GLPG
NASDAQ
Galapagos NV
Pharmaceutical Preparations
$27.73
-3.75% 1D
Market Cap
$1.9B
1M Return
-4.02%
1Y Return
+5.56%
Forward P/E
N/M
Unified AI Score
61.5 / 100
BUY
Tech 45.0
Fund 52.0
Flow 50.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BHST -79.4%
GLPG +5.56%
Spread: +25.82 pp (GLPG Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BHST TTM Op. Margin: -18.0%
GLPG TTM Op. Margin: 88.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BHST vs GLPG. Trailing 12-month operating profitability (BHST -18.0% vs GLPG 88.0%) and valuation multiples (BHST N/M vs GLPG N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BHST | GLPG | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $29.9M | $1.9B | Larger Scale | GLPG |
| Trailing P/E Ratio Valuation | N/M | 5.1x | Lower Multiple | GLPG |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +3.8% | +1093.2% | Higher Growth | GLPG |
| Operating Margin (TTM) Profitability | -18.0% | 88.0% | Higher Margin | GLPG |
| Net Profit Margin Profitability | -31.2% | 28.8% | Higher Margin | GLPG |
| Return on Equity (ROE) Capital Efficiency | -142.5% | 10.4% | Higher ROE | GLPG |
| 52-Week Range Position Momentum | 6% ($1โ$7) | 23% ($25โ$38) | Stronger Trend | GLPG |
| Beta / 30D Volatility Risk Regime | 0.25ฮฒ ยท 86% Vol | 0.71ฮฒ ยท 20% Vol | Lower Realized Risk | GLPG |
| Unified Institutional Score Composite Signal | 58.2 / 100 (HOLD) | 61.5 / 100 (BUY) | Higher Composite | GLPG |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BHST vs GLPG Buy Guide
BHST
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
GLPG
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
2nd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BHST nor GLPG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.